Our data show that PAM + ANL combination downregulates HIF1-α expression via the PI3K/Akt pathway (Figures 5F–I), and this new evidence extends the understanding of ANL’s regulation of AKT-HIF1α axis to immunomodulatory effects, beyond direct inhibition of tumor cell proliferation and stemness. The gene discussed is HIF1A; the disease is neoplasm.